Review vaccines offered from age 50
Shingles, pneumococcal and RSV vaccines prevent illnesses that hit harder as you get older.
The number, drawn
Why it matters
Three vaccines target illnesses that become more dangerous later in life. In adults aged 50 to 69 with healthy immune systems, Shingrix was 97% effective at preventing shingles in the studies CDC summarizes. CDC recommends pneumococcal vaccination from age 50, and a single RSV dose for everyone from 75 or from 50 with risk factors for severe illness.
How to do it
- Bring your vaccination record to a clinician or pharmacist and ask what you are missing.
- Ask about shingles vaccination from age 50, or from 19 with qualifying immune suppression, and book the second dose 2 to 6 months later.
- Ask about pneumococcal vaccination from age 50 under CDC guidance, or earlier with qualifying conditions.
- Ask about RSV vaccination from 75, or at ages 50 to 74 with risk factors; it is a single dose rather than an annual one.
- Check what your own country's programme offers, since schedules differ.
A clinician should check previous doses, immune suppression and other risk factors. For the shingles vaccine only, wait if you are pregnant or currently have shingles. RSV vaccination in pregnancy is a separate pathway at 32 to 36 weeks to protect the baby, so ask your maternity team. These vaccines do not prevent every cause of pneumonia.
Do it
Pick the time you have. Anything beats nothing.
Start with the time you have
1 minute
Recall whether you have had shingles, pneumococcal or RSV vaccines; flag any you cannot remember for a record review.
5 minutes
Ask a clinic or pharmacy for a vaccine record review under your country's age and risk criteria.
15 minutes
Gather vaccine dates, products and relevant health conditions; prepare separate questions about shingles, pneumococcal and RSV protection.
A plan
Review three vaccines together
- Collect your previous vaccine record.
- Have a vaccinator check each vaccine against local age, health and previous-dose criteria.
- Book any recommended vaccinations and further appointments.
- Keep the updated record so future reviews avoid unnecessary repeat doses.
In real life
- Ask your pharmacist to check shingles, pneumococcal and RSV vaccination against your record.
- If a shingles course needs another dose, book it for the date your vaccinator recommends.
Watch out for
- Common mistakeAn old pneumonia vaccination does not settle every pneumococcal decision, so bring the product and date for review.
- Common mistakeRSV vaccination is not currently an annual routine, so check your record before booking another.
Trusted guides
In Czechia
In Czechia, public insurance covers flu and pneumococcal vaccines from 65 and for people at risk, and tick-borne encephalitis vaccine from 50. If you choose a vaccine other than the cheapest one, you pay the difference.
In Germany, STIKO recommends the inactivated shingles vaccine for everyone from 60, and from 18 for people with a weakened immune system or a severe underlying disease. It takes two doses at least 2 and at most 6 months apart.
Bundesinstitut für Öffentliche Gesundheit, infektionsschutz.de checked
In Spain, shingles vaccination is recommended at age 65 as 2 doses at least 8 weeks apart, with cohorts aged 66 to 80 added progressively. Some risk groups are vaccinated from 18.
Ministerio de Sanidad checked
In the Netherlands, invitations for the free pneumococcal jab go this autumn to people born in 1966 and people born from 1948 to 1952, from the GP or institutional doctor in October and November.
RIVM checked
In Poland, the adult calendar recommends from age 50: pneumococcal vaccination (PCV13 then PPSV23, or one dose of PCV20 or PCV21), 2 doses of the RZV shingles vaccine, and 1 dose of RSV vaccine.
Szczepienia.info, NIZP PZH-PIB checked
Check usSources
- Evidence grade
- A Meta-analyses of randomised trials, or a major guideline consensus.
- Basis
- Randomized shingles vaccine efficacy summarized by CDC, plus CDC 2026 pneumococcal and RSV recommendations
- The number
- Shingrix was 97% effective against shingles in adults aged 50 to 69 with healthy immune systems (CDC, 2025)
- Outcome
- shingles in adults aged 50 to 69 with healthy immune systems
- Comparison
- Shingrix versus placebo in trials; not efficacy of RSV or pneumococcal vaccines
- Tier 1 guidelineShingles VaccinationCDC, 2025
- Tier 1 guidelineRecommended Vaccines for AdultsCDC, 2026
- Tier 1 guidelineRSV Vaccine Guidance for AdultsCDC, 2026
General health information, not a diagnosis or an individual treatment plan. Personalization changes the order of suggestions; it does not assess your medical risks. Follow the cautions and consult a qualified clinician when needed.